Sign in
8-K

Current Report

Oncotelic Therapeutics, Inc. Filed Acc 0000950135-07-001386

Material agreement · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading b64453oxe8vk.htm…